ArticleHealthcare (Basel, Switzerland)2025
Neutralizing Antibody Response to SARS-CoV-2 Variants After Two mRNA COVID-19 Vaccine Doses in a Cohort of Patients with Inflammatory Bowel Disease from a Southern Italy Tertiary Hospital.
Dario Genovese et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.